Cosmos Health Inc. (COSM)
$1.82
+0.05 (+2.82%)
Rating:
Recommendation:
-
| Symbol | COSM |
|---|---|
| Price | $1.82 |
| Beta | 3.013 |
| Volume Avg. | 1.55M |
| Market Cap | 23.785M |
| Shares () | - |
| 52 Week Range | 0.068-23.84 |
| 1y Target Est | - |
| DCF Unlevered | COSM DCF -> | |
|---|---|---|
| DCF Levered | COSM LDCF -> | |
| ROE | -42.73% | Strong Sell |
| ROA | -20.75% | Sell |
| Operating Margin | - | |
| Debt / Equity | 21.48% | Neutral |
| P/E | -1.19 | Sell |
| P/B | 0.45 | Neutral |
Latest COSM news
About
Download (Excel)Mr. Grigorios Siokas
Healthcare
Drug Manufacturers—Specialty & Generic
NASDAQ Capital Market
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.